ici 170809 has been researched along with methysergide in 2 studies
| Studies (ici 170809) | Trials (ici 170809) | Recent Studies (post-2010) (ici 170809) | Studies (methysergide) | Trials (methysergide) | Recent Studies (post-2010) (methysergide) |
|---|---|---|---|---|---|
| 14 | 1 | 0 | 2,935 | 81 | 80 |
| Protein | Taxonomy | ici 170809 (IC50) | methysergide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0021 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.631 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.807 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 4.763 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.054 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.943 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.013 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0021 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.054 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.172 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0006 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.162 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, T; Edvinsson, L; Eriksen, K; Jansen, I | 1 |
| Frenken, M; Kaumann, AJ | 1 |
2 other study(ies) available for ici 170809 and methysergide
| Article | Year |
|---|---|
5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries.
Topics: Cerebral Arteries; Humans; In Vitro Techniques; Methysergide; Muscle, Smooth, Vascular; Quinolines; Receptors, Serotonin; Serotonin Antagonists; Temporal Arteries; Vasoconstriction | 1991 |
Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
Topics: Animals; Cattle; Dose-Response Relationship, Drug; In Vitro Techniques; Methylation; Methysergide; Quinolines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Vasoconstriction | 1989 |